We're proud to announce that the NOVOS Core clinical study has officially been peer-reviewed and published in European Heart Journal Open, a journal of the European Society of Cardiology.
As Mayo Clinic scientist Dr. Doina Kulick put it:
“They are one of the few supplement companies, particularly in the field of healthy aging, that is going beyond mechanistic reasoning or animal studies. They are conducting clinical trials in the most rigorous fashion: randomized controlled, double-blinded.”
Cardiovascular health plays an important role in how we age, and these findings add to the growing body of research exploring how targeting multiple biological processes of aging may support long-term health.
For us, this publication represents an important step toward our mission: making healthy aging a science we can measure, study, and act on.
*NOVOS Core results after 6 months of daily use, placebo-adjusted, in healthy adults over 40. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
As Mayo Clinic scientist Dr. Doina Kulick put it:
“They are one of the few supplement companies, particularly in the field of healthy aging, that is going beyond mechanistic reasoning or animal studies. They are conducting clinical trials in the most rigorous fashion: randomized controlled, double-blinded.”
Cardiovascular health plays an important role in how we age, and these findings add to the growing body of research exploring how targeting multiple biological processes of aging may support long-term health.
For us, this publication represents an important step toward our mission: making healthy aging a science we can measure, study, and act on.
*NOVOS Core results after 6 months of daily use, placebo-adjusted, in healthy adults over 40. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.